OpenVSafe by OpenVAERS
Search V-safe

8SA-12847-28565

2 vaccinations 8 coded responses 17 check-ins 8 free-text entries 4 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
532 / WI
Registered
2021-03-04
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-04
    Registered in v-safe
  2. 2021-03-04
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-04
    Survey response — day 0, dose 1
    MedDRA: Visual impairment — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Distorted vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-03-11
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-03-18
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-25
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  11. 2021-04-01
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-01
    Survey response — day 0, dose 2
    MedDRA: Unevaluable event — Feeling: Good
    Free text: Just got an hour ago so nothing to report yet
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Headache, Muscle or body aches, Nausea, Vomiting
    Adult check-in
  14. 2021-04-10
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-15
    Survey response — day 14, dose 2
    MedDRA: Metamorphopsia, Nausea, Photophobia — Feeling: Good
    Free text: I was out of the country the first week of vaccination but had distorted vision and light sensitivity after the second shot for the first day. I had nausea for two days.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-24
    Survey response — day 21, dose 2
    MedDRA: Nausea — Feeling: Fair · Be unable to work
    Free text: Severe nausea the last two weeks
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-13
    Survey response — day 42, dose 2
    MedDRA: Gastrointestinal disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Severe GI issues since vaccinated
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-13
    Report sent to call center — day 42, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-01
    Survey response — 3 months, dose 2
    MedDRA: Dizziness, Impaired gastric emptying — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Have developed gastroparesis and dizzy spells possibly POTS
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-07-01
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  21. 2021-07-06
  22. 2021-07-12
  23. 2021-07-17
  24. 2021-09-30
    Survey response — 6 months, dose 2
    MedDRA: Flatulence, Post-acute COVID-19 syndrome, Postural orthostatic tachycardia syndrome, Unevaluable event, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Symptoms: Developed POTS and gas tripwires is from the virus and seem tnhave long covid · Healthcare visit (other): Several testing appointments and scans
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-09-30
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  26. 2021-10-01
  27. 2021-10-01
    Call successful
    Completed over the phone
  28. 2022-04-01
    Survey response — 12 months, dose 2
    MedDRA: Postural orthostatic tachycardia syndrome, Vertigo — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Still have vertigo and POTS
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-04-01
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  30. 2022-04-05
  31. 2022-04-08
  32. 2022-04-08
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-03-04Pfizer-BioNTech
22021-04-01Pfizer-BioNTech

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-04

Systemic reaction (other): Distorted vision

Release 6 — day 0, dose 2

2021-04-01

Systemic reaction (other): Just got an hour ago so nothing to report yet

Release 7 — day 14, dose 2

2021-04-15

Symptoms: I was out of the country the first week of vaccination but had distorted vision and light sensitivity after the second shot for the first day. I had nausea for two days.

Release 7 — day 21, dose 2

2021-04-24

Symptoms: Severe nausea the last two weeks

Release 8 — day 42, dose 2

2021-05-13

Symptoms: Severe GI issues since vaccinated

Release 9 — 3 months, dose 2

2021-07-01

Symptoms: Have developed gastroparesis and dizzy spells possibly POTS

Release 9 — 6 months, dose 2

2021-09-30

Symptoms: Developed POTS and gas tripwires is from the virus and seem tnhave long covid
Healthcare visit (other): Several testing appointments and scans

Release 11 — 12 months, dose 2

2022-04-01

Symptoms: Still have vertigo and POTS

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDDizziness ✓ ✓ ✓
SDFlatulence · · ✓
SDGastrointestinal disorder ✓ ✓ ✓
SDImpaired gastric emptying ✓ ✓ ✓
SDMetamorphopsia ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPhotophobia ✓ ✓ ✓
SDPost-acute COVID-19 syndrome · · ✓
SDPostural orthostatic tachycardia syndrome · · ✓
SDVertigo · · ✓
SDViral infection · · ✓
SROUnevaluable event ✓ ✓ ✓
SROVisual impairment ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release